[Hypertension in Chronic Kidney Disease]

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Internal Medicine

Background:

• Chronic kidney disease (CKD) progression is often independent of the initial cause once kidney function declines.
• Hypertension is a significant risk factor for CKD progression in both pediatric and adult populations.
• Achieving optimal blood pressure control (130/80 mmHg) is a primary therapeutic goal but rarely met.

Purpose of the Study:

• To review the role of hypertension in CKD progression.
• To outline effective pharmacological and non-pharmacological strategies for blood pressure management in CKD patients.

Main Methods:

• Review of current literature on hypertension and CKD.
• Analysis of therapeutic guidelines for managing blood pressure in CKD.
• Evaluation of drug classes including ACE inhibitors, ARBs, and diuretics.

Main Results:

• Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) are most effective for proteinuric CKD.
• Dietary salt restriction can help manage extracellular volume expansion.
• Thiazide diuretics are suitable for mild CKD; loop diuretics are needed for advanced CKD.

Conclusions:

• Effective blood pressure management is essential for slowing CKD progression.
• A combination of pharmacologic and non-pharmacologic interventions is often required.
• Tailored diuretic therapy based on CKD stage is necessary for optimal outcomes.